Uveitis Completed Phase 2 Trials for Adalimumab (DB00051)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02929251Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory UveitisTreatment
NCT00525902Adalimumab (Humira) in the Treatment of Refractory Non-infectious UveitisTreatment